CD4+CD25+ regulatory T cells in transplantation: Progress, challenges and prospects

American Journal of Transplantation

Volumn 7, Issue 6, 2007, Pages 1457-1463

  Kang, S M ^a   Tang, Q ^a   Bluestone, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dendritic cell; Immunology; T regulatery cells; Tolerance induction; Transplantation

Indexed keywords

ABATACEPT; ALEMTUZUMAB; BELATACEPT; CALCINEURIN INHIBITOR; CD4 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; COLECALCIFEROL; CYTOKINE; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 9; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; DRUG EFFECT; EXPERIMENTAL TRANSPLANTATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MAST CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; ANTIGENS, CD4; AUTOANTIGENS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION IMMUNOLOGY;

EID: 34248679904     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01829.x     Document Type: Short Survey

References (57)

1. Hall BM, Jelbart ME, Gurley KE et al. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 1985 162 : 1683 1694.
2. Quigley RL, Wood KJ, Morris PJ. Mediation of the induction of immunologic unresponsiveness following antigen pretreatment by a CD4 (W3/25+) T cell appearing transiently in the splenic compartment and subsequently in the TDL. Transplantation 1989 47 : 689 696.
3. Qin S, Cobbold SP, Pope H et al. Infectious transplantation tolerance. Science 1993 259 : 974 977.
4. Bushell A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995 25 : 2643 2649.
5. Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995 155 : 1151 1164.
6. Kim J, Rasmussen J, Rudensky A. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007 8 : 191 197.
7. Akl A, Luo S, Wood KJ. Induction of transplantation tolerance-the potential of regulatory T cells. Transpl Immunol 2005 14 : 225 230.
8. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3 : 199 210.
9. Trenado A, Charlotte F, Fisson S et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003 112 : 1688 1696.
10. Itoh M, Takahashi T, Sakaguchi N et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999 162 : 5317 5326.
11. Fontenot JD, Rasmussen JP, Williams LM et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005 22 : 329 341.
12. Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006 203 : 1701 1711.
13. Jordan MS, Boesteanu A, Reed AJ et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001 2 : 301 306.
14. Bushell A, Jones E, Gallimore A et al. The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. J Immunol 2005 174 : 3290 3297.
15. Fu S, Zhang N, Yopp AC et al. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am J Transplant 2004 4 : 1614 1627.
16. Chen D, Zhang N, Fu S et al. CD4+ CD25+ regulatory T-cells inhibit the islet innate immune response and promote islet engraftment. Diabetes 2006 55 : 1011 1021.
17. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 : 235 238.
18. Ochando JC, Homma C, Yang Y et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006 7 : 652 662.
19. You S, Leforban B, Garcia C et al. Adaptive TGF-β-dependent Regulatory T cells control spontaneous autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci, in press.
20. Roncarolo MG, Gregori S, Battaglia M et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006 212 : 28 50.
21. Vieira PL, Christensen JR, Minaee S, O'Neill EJ et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 2004 172 : 5986 5993.
22. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005 206 : 232 259.
23. Sun JB, Raghavan S, Sjoling A et al. Oral Tolerance Induction with Antigen Conjugated to Cholera Toxin B Subunit Generates Both Foxp3+CD25+ and Foxp3-CD25- CD4+ Regulatory T Cells. J Immunol 2006 177 : 7634 7644.
24. Liu J, Liu Z, Witkowski P et al. Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 2004 13 : 239 247.
25. Chang CC, Ciubotariu R, Manavalan JS et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002 3 : 237 243.
26. Chen W, Ford MS, Young KJ et al. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses. Cell Mol Immunol 2004 1 : 328 335.
27. Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001 167 : 1137 1140.
28. Serra P, Amrani A, Yamanouchi J et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 2003 19 : 877 889.
29. Tang Q, Adams JY et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006 7 : 83 92.
30. Tadokoro CE, Shakhar G, Shen S et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 2006 203 : 505 511.
31. Yamazaki S, Inaba K, Tarbell KV et al. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 2006 212 : 314 329.
32. Gregori S, Giarratana N, Smiroldo S et al. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003 171 : 4040 4047.
33. You S, Belghith M, Cobbold S et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 2005 54 : 1415 1422.
34. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005 6 : 135 142.
35. Lu LF, Lind EF, Gondek DC et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006 442 : 997 1002.
36. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003 197 : 451 460.
37. Salomon B, Lenschow DJ, Rhee L et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 12 : 431 440.
38. Tang Q, Henriksen KJ, Bi M et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004 199 : 1455 1465.
39. Sanchez-Fueyo A, Sandner S, Habicht A et al. Specificity of CD4+CD25+ regulatory T cell function in alloimmunity. J Immunol 2006 176 : 329 334.
40. Suchin EJ, Langmuir PB, Palmer E et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 2001 166 : 973 981.
41. Schenk S, Kish DD, He C et al. Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells. J Immunol 2005 174 : 3741 3748.
42. Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB. The balance of deletion and regulation in allograft tolerance. Immunol Rev 2003 196 : 75 84.
43. Golshayan D, Jiang S, Tsang J et al. In vitro expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 2007 109 : 827 835.
44. Masteller EL, Warner MR, Tang Q et al. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005 175 : 3053 3059.
45. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003 299 : 1033 1036.
46. He H, Stone JR, Perkins DL. Analysis of robust innate immune response after transplantation in the absence of adaptive immunity. Transplantation 2002 73 : 853 861.
47. Chen L, Wang T, Zhou P et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006 6 : 2282 2291.
48. Weaver CT, Harrington LE, Mangan PR et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006 24 : 677 688.
49. Maloy KJ, Salaun L, Cahill R et al. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003 197 : 111 119.
50. Muthukumar T, Dadhania D, Ding R et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005 353 : 2342 2351.
51. Battaglia M, Stabilini A, Migliavacca B et al. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006 177 : 8338 8347.
52. Zheng XX, Sanchez-Fueyo A, Sho M et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 2003 19 : 503 514.
53. Segundo DS, Ruiz JC, Izquierdo M et al. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 2006 82 : 550 557.
54. Lopez M, Clarkson MR, Albin M et al. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 2006 17 : 2844 2853.
55. Pearl JP, Parris J, Hale DA, Hoffmann et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5 : 465 474.
56. Tang Q, Henriksen KJ, Boden EK et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 2003 171 : 3348 3352.
57. Hirose K, Posselt AM, Stock PG et al. Treatment of kidney transplant patients with the novel co-stimulatory blocker LEA29Y (BMS-224818) and anti-IL2 receptor antibody does not impede the development of regulatory T cells. Am J Transplant 2004 4 : 442 442.